# Replimune Group, Inc.: Form 8-K, filed Sep 7, 2023

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2023-09-07
- Accepted by EDGAR: Sep 7, 2023, 09:17 ET
- Period: 2023-09-06
- Accession: 0001104659-23-098814
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923098814/tm2325666d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465923098814/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465923098814/tm2325666d1_8k.htm

Filed Sep 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-098814. Last ingested by Listed: Nov 11, 2026, 01:43 ET. No prices; not investment advice.
